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Abstract 
The isomeric structure of high-mannose N-glycans can significantly impact biological recognition 
events. Here, the utility of travelling-wave ion mobility-mass spectrometry (TW IM-MS)for isomer 
separation of high-mannose N-glycans is investigated. Negative ion fragmentation using collision-
induced dissociation (CID) gave more informative spectra than positive ion spectra with mass-different 
fragment ions characterizing many of the isomers. Isomer separation by ion mobility in both ionization 
modes was generally limited, with the arrival time distributions (ATD) often showing little sign of isomers. 
However, isomers could be partially resolved by plotting extracted fragment ATDs of the diagnostic 
fragment ions from the negative ion spectra and the fragmentation spectra of the isomers could be 
extracted by using ions from limited areas of the ATD peak. In some cases, asymmetric ATDs were 
observed but no isomers could be detected by fragmentation. In these cases, it was assumed that 
conformers were being separated. Collision cross sections (CCSs) of the isomers in positive and 
negative fragmentation mode were estimated from TW IM-MS data using dextran glycans as calibrant. 
More complete CCS data were achieved in negative ion mode by utilizing the diagnostic fragment ions. 
Examples of isomer separations are shown for N-glycans released from the well-characterized 
glycoproteins chicken ovalbumin, porcine thyroglobulin and gp120 from the human immunodeficiency 
virus. In addition to the cross sectional data, details of the negative ion collision-induced dissociation 
(CID) spectra of all resolved isomers are discussed.   
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Introduction 
Glycans play a key role in the folding of cell-surface and secreted glycoproteins and their chemical 
composition and precise isomeric structure can determine glycoprotein activity and biological 
recognition events1,2 . These functions are wide ranging and include recognition by endogenous lectins 
recognition in intracellular glycoprotein trafficking, cellular targeting, and glycoprotein turnover and even 
activity. Similarly, glycans also play an important role in self/non-self discrimination in the immune 
system3. Approximately half of all proteins are estimated to be glycosylated either at serine or threonine 
(termed O-linked) or at asparagine in an Asn-Xxx-Ser(Thr) motif where Xxx is any amino acid except 
proline (termed N-linked)4. The N-linked glycans are biosynthesised by the pathway outlined in Scheme 
15. In most species, including mammals, the glycan Glc3Man9GlcNAc2 (1) is first attached to the protein 
and then reduced to Man5GlcNAc2 (17) by the action of a series of glycosidases. -Glucosidases first 
remove the three glucose residues to give Man9GlcNAc2 (4) after which 1→2-mannosides remove the 
outer mannose residues from all three antennae to give Man5GlcNAc2 (17). These glycans are termed 
“high-mannose” glycans. GlcNAc-transferase I then adds a GlcNAc residue to the 3-(d1) antenna of 
Man5GlcNAc2 (17, the three antennae are numbered as shown in structure 17) to produce glycan 20 
which is a substrate for further mannosidase action to remove the two mannose residues from the 6- 
(d3) antenna to give 19. This glycan is then a substrate for further glycosyltransferases that add 
residues to form a series of complex glycans (discussed in a future paper). A second pathway involving 
the action of an endomannosidase on glycan 1 cleaves the terminal mannose with its attached glucose 
residues to give a second isomer of Man8GlcNAc2 (6) which is eventually degraded to 17 by -
mannosidases.  
 
High-mannose glycans have emerged as key targets in vaccine design against the human 
immunodeficiency virus (HIV)6,7. HIV is an enveloped virus with the sole target for antibody 
neutralisation being the glycoprotein, Env, containing a trimer of gp120/gp41 heterodimers. 
Approximately 50% of the mass of gp120 is formed by N-linked glycosylation and this high density of 
glycans leads to steric obstruction of the typical biosynthetic pathway of mannosidase cleavages and 
development of complex glycans8,9 resulting in about two thirds of the glycans being stalled at the high 
mannose stage9. Importantly, broadly neutralising antibodies have been identified that bind epitopes 
dominated by these conserved high-mannose glycans10,11. Their analysis is, thus, important in the 
structural elucidation of these epitopes and in the design and quality control of vaccine candidates12.  
 
For structural analysis, N-glycans are typically released from the glycoproteins by chemical or 
enzymatic processes and analysed by techniques such as high-performance liquid chromatography 
(HPLC), often with exoglycosidase digestion or mass spectrometry (MS)13-17. One of the problems 
encountered with these analyses is that many of the glycans are typically released as mixtures of 
isomers. Mass spectrometry, normally performed in positive ion mode, is useful in assigning 
compositions and providing branching and linkage information from these compounds but it is not a 
very powerful technique for discriminating between isomers. Prior separation by chromatographic inlet 
systems is, thus, frequently used with consequent increases in analysis time.  
 
Positive ion mass spectrometry methods using native, permethylated18-21 or reducing terminal-
derivatized glycans22,23 are the techniques used by most investigators although the newer methods 
such as electron-transfer dissociation (ETD)24,25, electron-detachment dissociation (EDD)26,27 and 
electronic excitation dissociation (EED)28 are being increasingly employed. Spectra produced by these 
techniques are often rich in structural details but often difficult to interpret because the branched nature 
of N-glycans and the presence of many fragments formed by concomitant losses of sugar residues in 
glycosidic cleavages (between the sugar rings) from several sites. We have been investigating the use 
of negative ion fragmentation for such studies and have found that the relatively simple spectra, that 
contain mainly cross-ring fragments, are much easier to interpret and provide more specific structural 
information than positive ion spectra. Such information includes the ability to detect isomers because 
of mass shifts in diagnostic ions rather than the abundance differences typical of positive ion spectra29-
32.  
 
Ion mobility mass spectrometry (IM-MS) is also of potential use for isomer separation because it relies 
not only on the mass and charge but also on the size and shape of the glycans for separation and has 
recently become commercially available on research-grade instruments. The object of the present work 
is to evaluate its use, combined with negative ion fragmentation, for structural studies on the high-
mannose glycans. Ion mobility has already proved to be an excellent method for examining N-glycans33-
51, particularly where sample amounts are limited52, and has been used to extract glycan ions from 
complex mixtures, particularly in cases where samples contain only small amounts of glycan and large 
amounts of other compounds such as buffer salts39,41,53-56. Separation of peptides from glycopeptides 
has also been reported57. If isomer separation were also to be realised by ion mobility, its combination 
with negative ion fragmentation would provide one of the most powerful methods for glycan identification 
available. 
 
Isomer separation by ion mobility has been shown for small carbohydrates (mono- to 
octasaccharides)58-79 and several N-glycans47,49 but resolution on current commercial instruments80 is 
usually only sufficient to resolve small carbohydrates. Nevertheless, Jackson et al.81 have been able to 
differentiate the larger compounds, GD1a and GD1b glycosphingolipids as caesium adducts; these 
compounds are isomeric in that they have sialic acid attached to different portions of the hexasaccharide 
moiety. Isailovic et al.45 have noted differences in the arrival time distribution (ATD) profiles of sialylated 
biantennary N-glycans from human serum but specific structures were not identified. Plasencia et al.47 
observed three peaks in the drift time profile from the doubly charged ion from the glycan of composition 
Hex5GlcNAc4 (per-methyl derivative) obtained from chicken ovalbumin and proposed three isomeric 
structures although, again, these structures were not confirmed by fragmentation. High-mannose N-
glycans do not appear to have been extensively studied by ion mobility to date82. This paper evaluates 
the use of travelling-wave ion mobility mass spectrometry (TW IM-MS), combined with negative ion 
fragmentation, for determining the structures of high-mannose glycans released from several 
glycoproteins with particular reference to HIV gp120 glycans33,38. 
 
Materials and Methods 
Materials 
N-linked glycans were released with hydrazine83,84 from the well-characterised glycoproteins 
ribonuclease B85,86 (compounds 4, 7, 11, 14, 17), porcine thyroglobulin87,88 (compounds 4, 7, 10, 11, 
14, 17), chicken ovalbumin89-91 (compounds 11, 14, 17, 19) and bovine fetuin92 obtained from Sigma 
Chemical Co. Ltd., Poole, Dorset, UK. N-glycans from gp120 expressed in human embryonic kidney 
(HEK) 293T cells (compounds 4, 7, 10, 11, 14, 17) were released with protein N-glycosidase F (PNGase 
F) from within NuPAGE gels essentially as described by Küster et al.41,93. Briefly, the glycoprotein (20 
g) was separated from other glycoproteins on sodium dodecyl sulfate (SDS) polyacrylamide 
electrophoresis (PAGE) gels (NuPage 4-12% Bis-Tris SDS-PAGE gel (Invitrogen, Paisley, UK)) using 
3-(N-morpholino)propanesulfonic acid (MOPS) running buffer (Invitrogen). After staining with 
Coomassie blue dye, the band containing the glycoprotein was excised, destained, and PNGase F (6 
mM sodium bicarbonate buffer pH 7.5) was infused into the gel. The gel pieces were incubated 
overnight (about 16 hours) at 37°C and the released glycans were extracted with several additions of 
water. For glycan purification, the solution was filtered with an 0.45 m hydrophobic protein binding 
Immobilon membrane held in a 96-well MultiScreen sterile plate (Millipore, Billerica, MA, USA). The 
glucose-containing high-mannose glycans (compounds 1, 22, 23) and the glycan (6) produced by the 
endomannosidase pathway, were obtained from cells treated with the -glucosidase-inhibiting 
compound N-butyl-deoxynojirimycin (NB-DNJ). The d1d2d3-isomer of Man8GlcNAc2 (6), and the d3-
isomer of Man6GlcNAc2 (13) were obtained from gp120 from the JRCSF clade of HIV grown in the 
presence of the -mannosidase inhibitor, kifunensine. The Man8GlcNAc2 d1d1d2 isomer (5) and two 
glycans (26, 27, Scheme 2) containing the mannose branch on the 3-antenna were from a 
Saccharomyces cerevisiae mutant and were gifts from Dr S. E. H. Moore and I. Chantret (Paris). 
Compounds 15 and 21 were from gp120 that had been treated with -mannosidase. Reference 
samples of Man5GlcNAc2 (17), Man6GlcNAc2 (d1 isomer, 14), Man7GlcNAc2 (d1,d1 isomer, 11), 
Man8GlcNAc2 (d1d1d3 isomer, 7) and Man9GlcNAc2 (4) were obtained from Dextra Laboratories, 
(Reading, UK). Methanol was obtained from BDH Ltd. (Poole, UK) and ammonium phosphate was from 
Aldrich Chemical Co. Ltd. (Poole) and BDH. Dextran from Leuconostoc mesenteroides was obtained 
from Fluka (Poole). 
 
All glycan samples were cleaned with a Nafion 117 membrane as described earlier by Börnsen et al.94. 
Samples were then dissolved in a solution of methanol:water (1:1, v:v) containing ammonium phosphate 
(0.05 M, to maximize formation of [M+H2PO4]- ions, the ions usually encountered from biological 
samples) and centrifuged at 10,000 rpm (9503 x g) for 1 min to sediment any particulates before 
examination by mass spectrometry.   
 
 
 
Ion mobility mass spectrometers 
TW IM-MS experiments were carried out mainly with a Waters Synapt G2 instrument (Waters Corp., 
Manchester UK)95 fitted with a nano-electrospray (n-ESI) ion source. Samples were infused through 
Waters thin-wall nanospray capillaries. The instrument was set up as follows: ESI capillary voltage, 1.2 
kV; cone voltage, 120 V, ion source temperature, 80°C; T-wave velocity, 450 m/sec; T-wave peak height 
40 V. The T-wave mobility cell contained nitrogen and was operated at a pressure of 0.55 mbar. 
Collision-induced dissociation (CID) was performed after mobility separation in the transfer cell with 
argon as the collision gas. The instrument was externally mass-calibrated with sialylated N-glycans 
released from bovine fetuin. The mobility cell was calibrated with (Glc)2-13 glycans present in dextran 
(from Leuconostoc mesenteroides) as described below. Data acquisition and processing were carried 
out using the Waters Driftscope (version 2.8) software and MassLynxTM (version 4.1). A few spectra 
(see text) were also obtained with the earlier version of the Synapt instrument (termed the G1 version) 
and with a Waters Synapt G2Si instrument using conditions similar to those above. The scheme devised 
by Domon and Costello96 was used to name the fragment ions with the following exception: the subscript 
R (for Reducing terminal) is used when general reference is made to loss of a GlcNAc residue from the 
reducing terminus of the glycan in order to avoid confusion caused by the subscript number changing 
as the result of altered chain lengths.  
 
CCS Estimation 
Absolute helium and nitrogen CCSs of singly charged dextran oligomers (Glc3-Glc13), measured 
previously using a modified Synapt high-definition (HDMS)97 (Waters) quadrupole/IMS/oa-TOF MS 
instrument containing a linear (not travelling wave) drift tube (DT) IM cell were used to estimate glycan 
CCSs from TW IM-MS data.98-100. Sample introduction and instrument set-up was as above. Estimation 
was performed with the method described by Thalassinos et al.101 and compared with measurements 
made using the drift tube instrument102. Extrapolated helium cross sections were obtained from the 
linear correlation plot (r2 = 0.99899) of the nitrogen and helium cross-section data from dextran obtained 
with the DT instrument (for positive ion data see100).  
 
Other spectra 
The spectrum of glucose-containing compound 25 (Scheme 1) was obtained with a Waters quadrupole-
time-of-flight (Q-Tof) Ultima Global instrument mass spectrometer. Samples in 1/1 (v/v) methanol:water 
containing 0.5 mM ammonium phosphate were infused through Proxeon (Proxeon Biosystems, 
Odense, Denmark) nanospray capillaries. The ion source conditions were: temperature, 120°C; nitrogen 
flow 50 L/hr; infusion needle potential, 1.2 kV; cone voltage 100 V; RF-1 voltage 150 V. CID spectra 
(argon, 2 sec scans) were acquired with a digitization rate of 4 GHz and processed as above. 
 
Results 
Calibration standard for collision cross section measurements 
Little has so far been published on calibration of TW IM-MS instruments in negative ion mode. Forsythe 
et al.103 have used polyalanine and polymalic acid but the mass range covered by these calibrants is 
insufficient for constructing a calibration for N-glycans. A general purpose calibration standard for 
calculating CCSs of N-glycans in the TW IM-MS instrument should ideally be a readily available glycan 
mixture104. Dextran oligomers from Leuconostoc mesenteroides would appear to fit these requirements. 
This mixture of glucose oligomers is readily obtainable and produces singly charged ions across the 
mass range covered by the N-glycans. Positive ion CCSs of the singly charged oligosaccharides were 
measured in nitrogen and helium with the DT IM-MS instrument and the nitrogen CCSs were calculated 
by the method described by Thalassinos et al.101. Peak centroids of the ATD peaks from the Glc2 to 
Glc13 oligomers from this dextran mixture were then measured with the TW IM-MS instrument, in 
nitrogen, and used to obtain a calibration in the form of y = Axn where y and x are the corrected dextran 
cross sections and drift times respectively. Full details have been published102. All cross sections will 
be added to the GlycoMob database (http://www.glycomob.org)105. 
 
High-mannose glycans, Positive ions 
Positive ion TWIMS nitrogen cross sections of the N-glycans released from the various glycoprotein 
samples recorded over a three year period were then measured and the results averaged and 
compared with the corresponding cross-sections measured with the linear instrument. Correlation was 
good across the range for the Man5-9GlcNAc2 glycans (4, 7, 11, 14, 17) (Table 1). Extrapolated helium 
cross-sections were estimated with the aid of the nitrogen:helium correlation plot and are also listed in 
Table 1. Again, these agreed reasonably well with those obtained directly with the linear instrument but 
were, in agreement with previous observations102, not as good as the nitrogen data. 
 
In order to see if any structural correlations could be made from the cross-section measurements, cross 
sectional data were plotted against hexose number for the high-mannose glycans (Figure 1). This plot 
shows a generally linear relationship for the Man5-7GlcNAc2 glycans and the d1d1d2-isomer (5) of 
Man8GlcNAc2 (see structure 17, Scheme 1 for the labelling of the antennae), but showed a shift towards 
longer drift times for the Man8GlcNAc2 d1d1d3-isaomer (7) and Man9GlcNAc2 (4) glycans. These 
glycans contained an additional mannose residue in the d3 branch of the 6-antenna. Although this 
relationship was consistently observed for the Man5-9GlcNAc2 glycans, it was not observed for the three 
glycans (1, 22, 23) containing the Glc3 substitution in the 3-antenna.  
 
Resolution of all isomers was not achieved in positive ion mode, but in negative mode many isomers 
could be partially resolved by examination of fragment ions. 
 
High-mannose glycans, Negative ions 
As emphasised in earlier publications29,32, negative ion fragmentation spectra of underivatized N-
glycans, although usually simpler than their positive ion counterparts, contain very diagnostic ions, 
mainly produced by cross-ring cleavages, and providing more specific structural information than 
positive ion spectra. Most significantly, isomers usually produced large mass differences in diagnostic 
fragment ions unlike many positive ion spectra where isomeric differences are reflected in the relative 
abundances of glycosidic fragment ions. This mass-different property allows ATDs of isomers to be 
extracted from fragmentation data by using profiles of isomer-specific fragments106,107. Many of the ions 
in the glycan mixtures obtained from the glycoproteins used in this work were produced by isomeric 
compounds, some of which gave clear mobility differences as reflected in bimodal or asymmetric ATD 
peaks. In some other cases, only slight broadening of the ATD peaks was observed. Nevertheless, the 
presence of isomers could still be detected by the mobility profiles of diagnostic negative ion fragments, 
as described in the examples below. Thus, cross sections of single compounds were calculated directly 
from the ATDs, whereas, when isomers were present, the relevant fragment ion peaks were sampled 
from their CID spectra obtained from the transfer cell. ATDs from these latter spectra exhibited an 
approximately 220 sec shift to shorter drift times than the corresponding unfragmented ATDs, requiring 
the relevant correction to be made. Using these methods, negative ion cross-sections were obtained 
for most of the isomeric high-mannose glycans in Scheme 1 and related compounds and are listed in 
Table 2. Validation of the method for measuring isomer cross sections from fragment ions was made 
by comparing the nitrogen values obtained using a linear drift cell with those of the isolated isomers 
(Dextra Laboratories) where close agreement was found (Table 2, Column 8). The values are also 
compared with those measured from the biological samples with the linear drift cell instrument; these 
latter values are the averages for glycans released from ovalbumin, ribonuclease B and porcine 
thyroglobulin100 because the lower resolution of this instrument did not permit isomer separation. They 
are listed against the most abundant isomer as determined with the Synapt G2 instrument in Table 2 
(Column 10). Agreement between the linear and TW IM-MS instruments was reasonable but not as 
good as with the reference isomers. 
 
General features of the negative ion fragmentation spectra 
Details of the negative ion fragmentation spectra for several of the compounds have been reported in 
earlier publications29,32,108, others are reported here. Briefly: 2,4AR, BR-1 and 2,4AR-1 ions (2,4A5, B5 and 
2,4A5 at m/z 1072, 1012 and 869 respectively in, for example, the spectrum of Man5GlcNAc2 (17) shown 
in Figure 2a) define the 1→4-linked chitobiose core, the D, D-18, 0,3AR-2, 0,4AR-2 and B2 ions (m/z 647, 
629, 575, 545 and 503 respectively in Figure 2a) and the D’ ion at m/z 323 define the branching pattern 
and the C1 ion at m/z 179 characterizes the hexose (mannose or glucose) residues on the non-reducing 
termini of the antennae. The D, D-18, 0,3AR-2, 0,4AR-2 and B2 ions will be referred to later in this paper as 
the “6-antenna-specific ions” and uniquely define all of the isomers expected in biological samples as 
shown in Table 3. It is important when recording the spectra of these compounds that the collision 
energy is not too high. As the collision energy rises, the fragmentation changes from that shown in 
Figure 2a to one in which the spectrum lacks the diagnostic fragments and is dominated by a series of 
(mannose)n-CH=CH-O- cross-ring fragments (Figure 3d) in a similar way to ions from endoH-released 
glycans  reported earlier109. For Man5GlcNAc2 (17), for example, shown in Figure 3, the diagnostic 
fragments are present in spectra recorded at about 75 V (Figure 3c) on the collision cell but are replaced 
by the other ions above 105 V. The plots in Figure 3a and b show the energy-resolved profiles for some 
of the main diagnostic ions (Figure 3a) and for the (mannose)n-CH=CH-O- cross-ring fragments (Figure 
3b). 
 
Man3-5GlcNAc2 (15, 17, 18, 19, 21) 
The spectrum of Man5GlcNAc2 (17) is reported above. The D and D-18 ions at m/z 323 and 305 in the 
spectrum of Man3GlcNAc2 (19, Figure 2e) were 324 mass units below the masses of the corresponding 
ions in the spectrum of Man5GlcNAc2 (17) reflected the absence of mannose residues attached to the 
6-antenna.  The spectrum shown in Figure 2c is of a mixture of the Man4GlcNAc2 isomers 15 and (18, 
21) as shown by the two sets of D, D-18, 0,3A3, 0,4A3 ions at m/z 323, 305, 251, 221 and at m/z 485, 467, 
413 and 383 respectively. The mixture gave a slightly asymmetric ATD peak (Figure 4a) consistent with 
the presence of isomers. ATDs of the D, D-18, 0,3A3, 0,4A3 ions (Figure 4b) showed that the ions in each 
set maximized at the same drift time but that there was a distinct difference between the drift times of 
each set showing partial separation of the isomers. The isomer with the longest drift time contained the 
fourth mannose in the 6-antenna (compounds 18 and 21) and represented a similar situation to the 
separation of isomers of Man3GlcNAc3, reported earlier49. These latter two compounds had the 
trimannosyl-chitobiose core with an additional GlcNAc residue substituted on either antenna with the 
compound containing the GlcNAc residue in the 6-antenna showing the longest drift time.  
 
By using only ions from the first part of the ATD peak of the Man4GlcNAc2 isomers, shown in Figure 4a, 
it was possible to extract a relatively clean spectrum of the 3-substituted isomer 15 (Figure 2b). The 
spectrum shown in Figure 2d is that of the isomer(s) (18 and 21) with the fourth mannose in the 6-
antenna. Not only did this method allow properties of the individual isomers to be extracted but it also 
confirmed that the presence of the two sets of diagnostic fragment ions seen in the total MS/MS spectra, 
as would be obtained without mobility separation, were indeed from isomeric compounds. 
 
CCSs of Man3GlcNAc2 (19) and Man5GlcNAc2 (17), calculated directly from the ATD peaks are listed 
in Table 2. CCSs of the Man4GlcNAc2 isomers (15, (18, 21)) were obtained from the ATD profiles of the 
diagnostic fragment ions with correction for the drift time offset mentioned above. 
 
Man6GlcNAc2 (12-14) 
Three biologically-relevant isomers (12-14) of this glycan are possible with the 6th mannose terminating 
one of the three antennae of 17. The d1 isomer (14, Figure 5c) is the most commonly found isomer in 
glycoproteins such as ribonuclease B and thyroglobulin and the fragment ions defining the branching 
pattern arising from the 6-antenna, are observed at the same m/z values as in the spectrum of 
Man5GlcNAc2 consistent with the presence of the 6th mannose in the 3-antenna. The d2-isomer (12) 
was obtained from gp120, JRCSF expressed in the presence of kifunensine. Its MS/MS spectrum 
(Figure 5b) showed a shift in the D, D-18, 0,3A3, 0,4A3 and B2 ions by 162 mass units to m/z 809, 791, 
737, 707 and 665 respectively reflecting the additional mannose residue in the 6-antenna. Its ATD 
profile was very similar to that of the d1 isomer (14).  
 
The d3 isomer (13) was obtained as a minor constituent of the glycans from gp120 that had also been 
expressed in the presence of the -mannosidase inhibitor kifunensine. The ATD peak at m/z 1493 
(phosphate adduct) was asymmetric (Figure 5a) and, consequently, the compound was fragmented in 
the transfer cell in order to extract the ATD of the isomeric constituents. Two sets of 6-antenna-specific 
fragment ions were present in the CID spectrum; those at m/z 647, 629, 575, 545 and 503 from the 
major compound showed that it was the d1 isomer (14). The other set of ions at m/z 809, 791, 737, 707 
and 665 maximized later (Figure 5b) and confirmed the presence of the second isomer with a mannose 
residue attached to the 6-antenna. Its spectrum was obtained by selecting only the right-hand portion 
of the total ATD peak and is shown in Figure 5c. Fragment ions in this spectrum were almost identical 
to those from the d2 isomer (12) but with the addition of the D’ and D’-18 ions at m/z 485 and 467. 
These latter ions were found to be diagnostic for mannose substitution in the d3 position and 
presumably arise in a similar manner to the D and D-18 ions because of the common 3,6-substitution 
pattern of the 6-antenna. The cross-section of this compound was obtained by correcting the drift time 
from the fragmentation spectrum by a factor equivalent to the difference between the drift time for the 
d1 isomer obtained from the mass spectrum and from the CID spectrum as described above. It was 
larger than that for the other two isomers, consistent with the observations made for d3-substituted 
high-mannose glycans in positive ion mode.  
 
 
Man7GlcNAc2 (8-11) 
Four isomers of this compound are possible: the d1d1 (11), d1d2 (8), d1d3 (10) and d2d3 (9) glycans. 
Spectra of the d1d1, d1d2, d1d3 isomers are shown in Figure 6. The d2d3 isomer (9) was not available. 
The spectrum of the d1d1-isomer (11, Figure 6a) contained 6-antenna-specific ions at the same masses 
as in the spectrum of Man5GlcNAc2 confirming no extra mannose residues in the 6-antenna. The 
spectra of the other two compounds (8, 10) showed a shift of these ions by 162 mass units consistent 
with the addition of one mannose to the 6-antenna. D’ and D’-18’ ions at m/z 485 and 467 respectively 
in the spectrum of 10 (Figure 6c) and their absence in spectrum 6b confirmed that spectrum 6c was 
that of the d1d3 isomer (10). Cross-section measurements of these isomers (Table 2) showed that the 
d1d3 isomer had a considerably larger cross section than the other two, consistent with the similar 
observation from the Man6GlcNAc2 isomers above. Samples from various preparations of gp120 
contained the d1d1 and d1d3 isomers in different proportions. Single ion mobilograms of the diagnostic 
D, D-18 etc. ions from one of these samples (inset to Figure 6a) showed separation of these isomers 
from a single spectrum. 
 
Man8GlcNAc2 (5-7) 
Spectra of the three possible isomers, d1d1d2 (5), d1d1d3 (7) and d1d2d3 (6) are shown in Figure 7. 
The 6-antenna-specific ions are present at m/z 809, 791, 737, 707 and 665 respectively in the spectra 
of the d1d1d2- (5) and d1d1d3- (7) isomers reflecting the presence of the single extra mannose residue 
in the 6-antenna. The two isomers can be differentiated by the presence of the ions at m/z 485 and 467 
in the spectrum of the d1d1d3-isomer (7) and by their cross sections; the isomer (5), missing the 
mannose on the 6-branch showed a significantly shorter drift time and smaller cross-section. The 
d1d2d3 isomer (6) displayed 6-antenna-specific ions at m/z 971, 953, 877, 869 and 827 confirming two 
additional mannose residues in the 6-antenna. Its CCS was also considerably higher than that of the 
d1d1d2-isomer (5), as expected from the presence of the mannose residue at the d3 position.  
 
The d1d1d3-isomer of Man8GlcNAc2 (7) is normally the major isomer in biological systems but, in most 
samples studied, its ATD peak was asymmetric (Inset, Figure 7a) with a slight shoulder on the leading 
edge suggesting the presence of a second isomer. Spectra extracted from the leading and trailing edges 
of the ATD peak following transfer cell fragmentation were virtually identical. The presence of the D’ 
and D-18’ ions at m/z 485 and 467 with the same mobility profile as that of the total ion profile showed 
that a minor isomer, if present, was also substituted at the d3 position and would, thus correspond to 
compound 6. Cross-section measurements of this compound, the d1d2d3-isomer, obtained as the 
product of endomannosidase digestion was less than that of the major d1d1d3-isomer (7) (although 
larger than that of the d1d1d2-isomer, 5) and was consistent with the shoulder on the major peak. Close 
inspection of the fragmentation spectrum showed very low abundance ions corresponding to the D, D-
18, 0,3A3, 0,4A3 and B2 ions expected from this isomer but which would not normally be of sufficient 
relative abundance to give confidence that they signified the presence of a second isomer. However, 
their different drift times from those of the major peaks confirmed their origin from compound 6. The 
presence of this isomer is consistent with the enzymology of the expression system use to produce the 
glycoprotein and shows that it is most probably formed as a product of an endomannosidase (Scheme 
1). 
 
Man9GlcNAc2 (4) 
Man9GlcNAc2 from ribonuclease B, thyroglobulin and gp120 is a single isomer (4) as would be expected 
on biochemical grounds and confirmed by its CID spectrum (Figure 8c). The 6-antenna-specific ions at 
m/z 871, 953, 877, 869 and 827 are consistent with the composition of the 6-antenna with the ions at 
m/z 485 and 467 reflected the presence of mannose in the d3 branch. The Synapt G1 instrument gave 
a roughly Gaussian peak for this glycan but the G2 instruments produced an asymmetric ATD peak 
from the glycan from all three glycoproteins (Figure 9a). ATD profiles of the diagnostic fragment ions all 
matched that of the molecular ion suggesting that conformers were being separated (Figure 9b). 
Reduction of the glycans (to be published) removed the asymmetry indicating that anomer separation 
was the main reason for the un-symmetrical ATDs. Anomer separation of small carbohydrates (mainly 
as [M+Na]+ ions from methyl glycosides) by ion mobility has been noted by several 
investigators34,58,59,68,110 and pronounced effects on the conformation of the GlcNAc-1→4GlcNAc 
disaccharide (equivalent to the chitobiose core of the N-linked glycans) have been noted by X-ray 
crystallography111,112 as reported by Wood et al113. However, the effect was not seen with the smaller 
high-mannose glycans suggesting that the anomer configuration can affect more than just the 
chitobiose core. For positive ion spectra ([M+Na]+ ions), Dwivedi et al.60 have proposed that separation 
reflects the way in which the sodium ion is bound to the glycan and a similar situation may exist for 
negative ion spectra. The CCS data from the G2 instrument are from smoothed ATD peaks. In some of 
the gp120 samples, a trace amount of a compound consistent with Glc1Man8GlcNAc2 (24) was detected 
as producing diagnostic ions at m/z 545 and 383 (see below) with ATDs matching that of the second 
peak. This compound has also been detected by HPLC in these gp120 samples but its abundance was 
not sufficient to account for the asymmetric ATD peak and it was not detected in the other samples. 
 
Glycans from Saccharomyces cerevisiae 
Two glycans, Man9GlcNAc2 (26) and Man10GlcNAc2 (27, Scheme 2) were obtained from 
Saccharomyces cerevisiae mutants with structures that differed from the above in that they contained 
an extra mannose at the 6-position of the internal mannose of the 3-antenna114. Their spectra are shown 
in Figure 8b and 8d respectively, together with those of Man8GlcNAc2 (d1d1d3 isomer 7, Figure 8a) and 
Man9GlcNAc2 (4, Figure 8c) for comparison, and their cross-sections are listed in Table 2. The d1d1d3- 
and d1d1d2d3-substitution of these glycans was confirmed by the D, D-18 series of ions and the 
absence of glucose residues on the 3-antenna (Hex10GlcNAc2 could be Glc1Man9GlcNAc2 (3) rather 
than Man10GlcNAc2, (27)) was reflected by the absence of the prominent cross-ring fragments at m/z 
545 and 383 (one glucose residue, see section below). The spectra were virtually identical to those of 
the corresponding glycans without the 6-substituted mannose in the 3-antenna meaning that no suitable 
diagnostic ion for this substitution was present. The ATD profiles from these two Saccharomyces 
cerevisiae glycans were symmetrical (Figure 9c) as were those of the 6-antenna-specific fragment ions 
(Figure 9d). 
 
Glc3Man7-9GlcNAc2 (1, 22, 23) 
These glycans were produced by expressing gp120 in CHO cells in the presence of the -glucosidase 
inhibitor N-butyl-deoxynojirimycin (NB-DNJ) which prevents removal of the glucose residues from 
Glc3Man9GlcNAc2 (1) at the start of N-glycan processing115 and, thus, prevents degradation of the 3-
antenna by exo-mannosidases. Under these conditions, the action of -mannosidase I only removes 
one and two mannose residues from the 6-antenna to give 22 and 23. 1,3A cross-ring fragmentation of 
the intact Glc3Man3 antenna of these compounds gave rise to the prominent ions at m/z 869 and 707 
(Figure 10c-d). D and D-18 ions appeared to be suppressed in the spectra of these compounds although 
the B3 ion at m/z 809 was prominent in the spectrum of Glc3Man9GlcNAc2 (1). The prominent ions at 
m/z 869 and 707 were diagnostic of these glycans with three glucose residues in the 3-antenna and 
dropped to 707:545 and to 545:383 for related glycans with two and one glucose residues respectively 
(Figure 10a). Unfortunately, the CID spectrum of compound 25 was recorded with a Q-TOF mass 
spectrometer, before the advent of the Synapt series of instruments and, consequently, its drift time 
was not available. 
 
The cross sections of the Glc3Man7 and 9GlcNAc2 glycans (23, 1) are listed in Table 2. Although the ATD 
profiles of Glc3Man7GlcNAc2 (23) and Glc3Man9GlcNAc2 (1) were roughly symmetrical, that from 
Glc3Man8GlcNAc2 (22) was very broad (first inset, Figure 10a). The fragmentation spectra extracted 
from all areas of the ATD peak were similar and the intact 3-antenna (confirmed by the presence of the 
ions at m/z 869 and 707) was consistent with the absence of one of the mannose residues from the 6-
antenna. However, some of the ATDs of the fragment ions, particularly m/z 971 (Hex6, B6) showed 
separation into two peaks but it was unclear if these represented the d1d1d2- and d1d1d3-isomers; the 
ion diagnostic for the d3 isomer maximized in the centre of the ATD peak. Possibly conformers were 
present and this point is being pursued further. 
 
A plot of all the measured CCSs against hexose number for all of the high-mannose glycans recorded 
in negative ion mode is shown in Figure 11. In general, the same features were apparent as seen in the 
corresponding positive ion plot (Figure 1). Thus, the Man8GlcNAc2 (7) and Man9GlcNAc2 (4) glycans 
with mannose at the d3 position again showed increased cross sections compared with those of their 
respective isomers. This observation was supported by the additional CCSs of the d3 isomer of 
Man6GlcNAc2 (13), and the d1d3 isomer of Man7GlcNAc2 (10), both of which showed larger cross 
sections than the isomers without the d3-mannose. No significant differences were seen in the cross 
sections of the glycans with extra mannose residues in the d1 and d2 positions. Again the results from 
the Glc3-containing glycans did not fit this pattern but may have been obscured by the presence of 
conformers causing considerable peak broadening.  
 
 
Discussion 
The above examples clearly show that ion mobility mass spectrometry adds a further dimension to the 
analysis of N-linked carbohydrates by mass spectrometry. Some isomeric separation was possible in 
both ion modes but could be detected more fully in negative ion mode where the presence of isomers 
was reflected by differences in the masses of certain diagnostic fragments. Characteristic drift-time 
increases were seen with glycans containing mannose substitution on the d3-branch of the 6-antenna. 
IM resolution is still rather poor on commercial instruments and for several of the high-mannose glycans, 
only peak broadening or asymmetric peaks suggested the presence of isomers. Unfortunately, similar 
results were seen in the presence of conformers, which were also partially separated by ion mobility 
mass spectrometry. However, because negative ion fragmentation frequently yields ions from isomers 
that differ in mass, individual ATDs of these ions show different maxima and, when superimposed on 
the total ATD profile, enabled isomers and conformers to be differentiated. The corresponding 
experiment performed upon conformers, not isomers, gave ATD traces from the fragment ions that 
matched the shape of the total ATD peak. 
 
The ability of ion mobility to separate isomers, albeit with rather low resolution at present, is a great 
asset. One of the main disadvantages of the use of mass spectrometry (without fragmentation) for 
glycan analysis at present is its inability to separate such compounds and, thus, identifying their 
presence in mixed spectra. The ion mobility resolution obtained with commercial instruments does not 
yet match that of an HPLC column but is expected to rise with further instrumental developments. 
Ultimately, it might be possible to achieve adequate separations in the gas phase in milliseconds rather 
than the tens or hundreds of minutes required at present with LC-MS systems, thus considerably 
expediting up analyses. 
 
Conclusions 
The work presented here, and by other investigators, shows that ion mobility mass spectrometry has 
much to offer in glycobiology and is able to solve problems such as isomer resolution that, up to now, 
have required techniques such as chromatography. With its ability to extract glycan ions from complex 
mixtures and, thus, eliminate some clean-up stages41, and with its combination with negative ion CID 
spectra, the technique provides a much more rapid and information-rich method for the structural 
determination of N-glycans than has been available up to now.  
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Legends for figures and schemes 
Scheme 1. Biosynthesis of the high-mannose glycans. The arrows show the relationship between the 
various glycans but do not necessarily imply the existence of specific enzymatic pathways. Symbols 
used for the glycans are  = mannose,  = GlcNAc and   = glucose. Solid lines connecting the 
symbols are -linkages, broken line are -linkages. The angle of the lines shows the linkage position. 
For more information see116. 
 
 
Scheme 2, Structure of the two glycans (26, 27) from yeast. Structures are drawn with the conventions 
outlined in Scheme 1. 
 
Figure 1. Plot of cross sections against number of hexose residues for the [M+Na]+ ions from the high-
mannose glycans. Numbers in bold are structure numbers from Scheme 1. 
 
Figure 2. Negative ion CID spectra ([M+H2PO4]- ions) of: (a) Man5GlcNAc2 (17, from gp120), (b) 
Man4GlcNAc2 (15, mobility-extracted, from gp120 as shown in Figure 4b), (c) Mixture of Man4GlcNAc2 
(15 and 21 from gp120), (d) Man4GlcNAc2 (21, mobility-extracted, from gp120 as shown in Figure 4b), 
(e) Man3GlcNAc2 (19, from chicken ovalbumin). Symbols used for the structural diagrams in these and 
other spectra are as described in the legends to Schemes 1 and 2. Fragment ions are labelled according 
to the scheme proposed by Domon and Costello96. 
 
Figure 3. (a and b) relationship between collision cell voltage and fragment ion abundance for 
structurally-diagnostic fragment ions (a) and hexose + O-CH=CH-O- ion (b). (c) Negative ion CID 
spectrum ([M+H2PO4]- ion) of Man5GlcNAc2 recorded at 75 V on the collision cell, (d) Negative ion CID 
spectrum ([M+H2PO4]- ion) of Man5GlcNAc2 recorded at 105 V on the collision cell.  
 
Figure 4. (a) Negative ion ATD profile (unsmoothed) of Man4GlcNAc2 (15, 18, 21, [M+H2PO4]- ions) 
from gp120. (b) ATDs of the diagnostic 6-antenna-specific fragment ions from Man4GlcNAc2 from gp120 
(“Mean” smoothing algorithm from MassLynx, window size = 2, number of smooths = 2). Ions are 
identified as in Figure 2. 
 
Figure 5. (a) Negative ion ATD profile (unsmoothed) of Man6GlcNAc2 ([M+H2PO4]- ion) from gp120. (b) 
Single ion plots of the diagnostic 6-antenna-specific fragment ions from Man6GlcNAc2 obtained from 
gp120 (smoothing algorithm, mean 2x2). (c) Negative ion CID spectrum ([M+H2PO4]- ion) of 
Man6GlcNAc2 (d1 isomer, 14, from bovine thyroglobulin). (d) Negative ion CID spectrum ([M+H2PO4]- 
ion) of Man6GlcNAc2 (d2 isomer, 12, from gp120 (JRCSF)). (e) Negative ion CID spectrum ([M+H2PO4]- 
ion) of Man6GlcNAc2 (d3 isomer, 13), extracted from the right-hand portion of the ATD peak shown in 
5a and 5b. 
 
Figure 6. (a) Negative ion CID spectrum ([M+H2PO4]- ion) of Man7GlcNAc2 (d1d1 isomer, 11, from 
porcine thyroglobulin). (b) Negative ion CID spectrum ([M+H2PO4]- ion) of Man7GlcNAc2 (d1d2 isomer, 
8, from gp120, (JRCSF)). Negative ion CID spectrum ([M+H2PO4]- ion) of Man7GlcNAc2 (d1d3 isomer, 
10, from gp120). The inset to the first panel shows single ion plots of the 6-antenna-specific ions 
(smoothing algorithm, mean 2x2) showing the presence of the minor isomer 11. The spectrum in panel 
c was, thus, from the right-hand portion of the ATD peak. 
 
Figure 7. (a) Negative ion ATD profile (smoothing algorithm, mean 2x2) of Man8GlcNAc2 ([M+H2PO4]- 
ion) from gp120. (b) Single ion plots of the diagnostic 6-antenna-specific fragment ions from 
Man8GlcNAc2 (mainly isomer 7) obtained from gp120 (smoothing algorithm, mean 2x2). (c) Negative 
ion ATD profiles (smoothing algorithm, mean 2x2) of the d1d1d2 (5) and d1d1d3 (7) isomers of 
Man8GlcNAc2 ([M+H2PO4]- ions). Spectra were from different samples and normalized to 100%. (d) 
Negative ion CID spectrum ([M+H2PO4]- ion) of Man8GlcNAc2 (d1d1d3 isomer, 7, from gp120). (e) 
Negative ion CID spectrum ([M+H2PO4]- ion) of Man8GlcNAc2 (d1d1d2 isomer, 5, from a Saccharomyces 
cerevisiae mutant117. (f) Negative ion CID spectrum ([M+H2PO4]- ion) of Man8GlcNAc2 (d1d2d3 isomer, 
6, from gp120 expressed in CHO cells in the presence of the -mannosidase inhibitor NB-DNJ. 
 
Figure 8. Negative ion CID spectra ([M+H2PO4]- ion) of: (a) Man8GlcNAc2 (d1d1d3 isomer, 7, from 
gp120). (b) Man9GlcNAc2 (26, d1d1d3 isomer with an extra mannose residue at position 6 of the internal 
mannose of the 3-antenna) from a Saccharomyces cerevisiae mutant (c) Man9GlcNAc2 (d1d1d2d3 
isomer (4) and (d) Man10GlcNAc2 (27, d1d1d2d3 isomer with an extra mannose residue at position 6 of 
the internal mannose of the 3-antenna) from a Saccharomyces cerevisiae mutant. 
 
Figure 9. (a) Negative ion ATD profile (smoothing algorithm, mean 2x2) of Man9GlcNAc2 (4, [M+H2PO4]- 
ion) from gp120. (b) Single ion plots of the diagnostic 6-antenna-specific fragment ions from 
Man9GlcNAc2 (4) obtained from gp120 (smoothing algorithm, mean 2x2). (c) Negative ion ATD profile 
(smoothing algorithm, mean 2x2) of Man9GlcNAc2 (26, [M+H2PO4]- ion) from a Saccharomyces 
cerevisiae mutant. (b) Single ion plots of the diagnostic 6-antenna-specific fragment ions from 
Man9GlcNAc2 (26 obtained from a Saccharomyces cerevisiae mutant (smoothing algorithm, mean 2x2). 
 
Figure 10. Negative ion CID spectra ([M+H2PO4]- ion) of: (a) Glc1Man7GlcNAc2 (25). (b) 
Glc3Man7GlcNAc2 (22). (c) Glc3Man8GlcNAc2 (23) and (d) Glc3Man9GlcNAc2 (1). Spectra b, c and d 
were from gp120 expressed in CHO cells in the presence of the -mannosidase inhibitor NB-DNJ. Inset 
1 to panel a shows the ATD profiles for Glc3Man7-9GlcNAc2, Inset 2 shows the fragmentation of 
Glc3Man9GlcNAc2 (1). 
 
Figure 11. Plot of cross sections against number of hexose residues for the [M+H2PO4]- ions from the 
high-mannose glycans. 
 
Abbreviations 
ATD, arrival time distribution; CHO, Chinese hamster ovary; CID, collision-induced dissociation; DT, 
drift tube; EDD, electron-detatchment dissociation; EED, electronic excitation dissociation; endoH, 
endoglycosidase H; ETD, electron-transfer dissociation; ESI, electrospray ionization; G1, Waters 
Synapt ion mobility mass spectrometer, first generation; G2, Waters Synapt ion mobility mass 
spectrometer, second generation; Glc = glucose; GlcNAc, N-acetylglucosamine; HDMS, high-definition; 
HEK, human embryonic kidney; HIV, human immunodeficiency virus; HPLC, high-performance liquid 
chromatography; Hex, hexose; LC, liquid chromatography; JRCSF, clade of gp120; Man, mannose; 
MS, mass spectrometry; n-ESI, nano-electrospray ionization; NB-DNJ, N-butyl-deoxynojirimycin; NMR, 
nuclear magnetic resonance; oa, orthogonal acceleration; PAGE, polyacrylamide gel electrophoresis; 
PNGase F, protein N-glycosidase F; Q-quadrupole; SDS, sodium dodecylsulfate; TOF, time-of-flight; 
TW IM-MS, travelling-wave ion mobility spectrometry. 
 
  
 
Table 1, Positive ion cross section measurements for high-mannose N-glycans 
 
Hexose Structure 
m/z 
[M+Na]+ 
Cross section data (Å2) 
TW IM-MS Published lineara 
Nitrogen Helium Nitrogen Helium 
Cross 
section 
SD n 
Calculated 
cross 
section  
Cross 
section 
(Å2) 
Cross 
section 
(Å2) 
3 19 933.3 303.5 1.19 3 219.3 294.2 209.7 
5 17 1257.4 353.9 2.30 11 265.8 354.2 261.8 
6 14 1419.5 376.3 2.05 11 286.2 376.1 278.2 
7 Mainly 11 1581.5 396.4 1.89 10 304.6 396.8 300.4 
8 7 1743.6 426.4 2.41 9 332.6 426.6 327.2 
9 4 1905.6 449.2 2.33 9 353.7 456.2 346.9 
 
a) Mean value from the glycans in ovalbumin, ribonuclease B and desialylated thyroglobulin. 
Table 2, Negative ion cross section measurements for high-mannose N-glycan 
 
Man Structure 
m/z 
[M+H2PO4)
- 
Isomer 
Cross section data (Å2) 
TW IM-MS Linear 
Nitrogen Helium Nitrogen Helium 
Cross 
section  
(Å2) 
SD n 
Reference 
sample 
Projected 
cross 
section  
(Å2) 
Cross 
section 
(Å2) 
Cross 
section 
(Å2) 
3 19 1007.3 - 282.8 - 2 - 204.9 282.4 201.4 
4 
15 
1169.3 
d1 305.6 - 1 - 225.6 
317.4 233.1 
18,21 d2(d3) 309.4 - 1 - 229.1 
5 17 1331.4 d1 340.0 2.20 13 344.8 265.1 347.7 264.8 
6 
14 
1493.5 
d1 366.5 2.40 13 367.7 280.1 372.4 291.9 
12 d2 363.0 - 1 - 276.7 - - 
13 d3 371.6 -  - 284.7 - - 
7 
11 
1655.5 
d1d1 386.5 1.11 7 389.1 297.9 396.2 312.8 
8 d1d2 387.7 - 1 - 299.2 - - 
10 d1d3 394.8 2.50 13 - 307.2 - - 
8 
7 
1817.6 
d1d1d3 418.9 3.69 9 416.7 327.4 422.3 335.7 
5 d1d1d2 400.2 - 2 - 310.5 - - 
6 d1d2d3 414.2 - 2 - 322.9 - - 
9 
4 
1979.6 
d1d1d2d3 439.0 2.63 9 431.7 345.1 442.4 354.3 
26 
d1d1d3,3-
Me 
438.0 - 1 - 344.3 - - 
10 27 2141.7 
d1d1d2d3-
3-Me 
459.6 - 1 - 363.8 - - 
G3M7 23 2141.7 d1d1 451.9 - 3 - 357.5 - - 
G3M8 22 2303.7 d1d1d3 482.0 - 1 - 384.4 - - 
G3M9 1 2465.8 d1d1d2d3 490.9 - 2 - 392.6 - - 
 
 
 
  
Table 3, Fragment ions in the negative ion CID spectra that uniquely define the isomers of the 
high-mannose N-glycans reported in this paper 
 
Glycan Isomer No. 
m/z 
([M+H2PO4]-) 
Structural evidence 
D D-18 0,4A 0,3A D’ D’-18 
Man4 - 18 1169.3 485.2 467.2 413.1 395.1 - - 
Man5 - 17 1331.4 647.2 629.2 575.2 545.2 323.1 305.1 
Man6 
d1 14 
1493.5 
647.2 629.2 575.2 545.2 323.1 305.1 
d2 12 809.3 791.3 737.2 707.2 323.1 305.1 
d3 13 809.3 791.3 737.2 707.2 485.2 467.2 
Man7 
d1d1 11 
1655.5 
647.2 629.2 575.2 545.2 323.1 305.1 
d1d2 8 809.3 791.3 737.2 707.2 323.1 305.1 
d1d3 10 809.3 791.3 737.2 707.2 485.2 467.2 
d2d3 9 971.3 953.3 899.3 869.3 485.2 467.2 
Man8 d1d1d2 5 
1817.6 
809.3 791.3 737.2 707.2 - - 
 d1d1d3 7 809.3 791.3 737.2 707.2 485.2 467.2 
 d1d2d3 6 971.3 953.3 899.2 869.3 485.2 467.2 
Man9 
d1d1d2d3 4 1979.6 971.3 953.3 899.3 869.3 485.2 467.2 
- 26 1979.6 809.3 791.3 737.2 707.2 485.2 467.2 
Man10 - 27 2141.7 971.3 953.3 899.3 869.3 485.2 467.2 
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